Hutch News
Results per Page:
Bone marrow transplant survival rates recognized nationally
Fred Hutch BMT program at SCCA earns national recognition for 6th consecutive year
3 big new leukemia research projects advance cutting-edge cell therapies, stem cell transplant
$20M renewal of 4-decade-long federal grant to Hutch scientists
Fred Hutch/SCCA transplant patient survival above the expected rate in U.S.
For 5th year in a row, bone marrow transplant program receives top recognition
Fred Hutch/SCCA transplant rates among best in U.S.
Fred Hutch Bone Marrow Transplant Program recognized for outperforming expected one-year survival rates for allogeneic transplant patients
Fred Hutch/SCCA transplant rates among best in U.S.
Nobel Prize-winning transplant program receives top recognition four years in a row.
Mielcarek study may change the practice of blood stem-cell transplantation
Celebrating faculty and staff achievements
Life with graft-vs.-host disease: When the transplant is just the beginning
How researchers are trying to combat this common, often debilitating side effect of treatment
Gentler treatment for many with graft-vs.-host disease
A new study finds halving standard steroid dose treats most acute GVHD just as well; could limit dangerous side effects
Mielcarek lands $2.2 million GVHD grant
NHLBI grant will expand research into protective mechanisms of statins against severe acute graft-vs.-host disease in transplant patients
Post-transplant survival: A study of the gap between ethnic groups
Mielcarek, colleagues cite transplant-diagnosis delays among possible reasons for poor survival rates for African-American patients